Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
Severe articular and musculoskeletal pain: An unexpected side effect of dimethyl-fumarate therapy for multiple sclerosis.
The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
Molecular dynamics at the receptor level of immunodominant myelin oligodendrocyte glycoprotein 35-55 epitope implicated in multiple sclerosis.
Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
The role of appraisal and coping style in relation with societal participation in fatigued patients with multiple sclerosis: a cross-sectional multiple mediator analysis.
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.
S100A8/A9: From basic science to clinical application.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Cognitive impairment in MS: rehabilitation approaches.
Task-dependent deterioration of balance underpinning cognitive-postural interference in MS.
EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers' Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a.
The effects of whole body vibration on muscle strength and functional mobility in persons with multiple sclerosis: A systematic review and meta-analysis.
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
[Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis].
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
Pregnancy in the Setting of Multiple Sclerosis.
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®.
Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology.
Efficacity of exercise training on multiple sclerosis patients with cognitive impairments.